Rigel Pharmaceuticals
RIGL
#6552
Rank
ยฃ0.65 B
Marketcap
ยฃ35.61
Share price
0.38%
Change (1 day)
68.21%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): ยฃ68.35 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.27 Billion. In 2025 the company made an earning of ยฃ97.53 Million, an increase over its 2024 earnings that were of ยฃ19.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ68.35 M-29.92%
2025 ยฃ97.53 M391.35%
2024 ยฃ19.85 M-244.27%
2023 -ยฃ13.77 Million-66.79%
2022 -ยฃ41.44 Million340.73%
2021 -ยฃ9.41 Million-56.15%
2020 -ยฃ21.45 Million-57.34%
2019 -ยฃ50.27 Million-7.66%
2018 -ยฃ54.44 Million-9.47%
2017 -ยฃ60.14 Million24.46%
2016 -ยฃ48.32 Million23.63%
2015 -ยฃ39.08 Million-43.29%
2014 -ยฃ68.92 Million2.5%
2013 -ยฃ67.24 Million
2010 ยฃ28.59 M-133.97%
2009 -ยฃ84.17 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ60.07 Million84.74%
2006 -ยฃ32.52 Million-10.17%
2005 -ยฃ36.2 Million-15.73%
2004 -ยฃ42.95 Million39.29%
2003 -ยฃ30.84 Million10.3%
2002 -ยฃ27.96 Million48.3%
2001 -ยฃ18.86 Million-2.13%
2000 -ยฃ19.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ7.76 B 11,157.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.82 B 15,583.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ83.33 Million-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-ยฃ98.64 Million-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA